Report Detail

Pharma & Healthcare Global (United States, European Union and China) Nicotinamide Phosphoribosyltransferase Market Research Report 2019-2025

  • RnM3348244
  • |
  • 14 July, 2020
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Nicotinamide Phosphoribosyltransferase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Phosphoribosyltransferase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nicotinamide Phosphoribosyltransferase market is segmented into
Hormone
Lipids
Small Molecule Compounds
Others

Segment by Application, the Nicotinamide Phosphoribosyltransferase market is segmented into
Parkinson's Disease
Acute Lung Injury
Breast Cancer
Others

Regional and Country-level Analysis
The Nicotinamide Phosphoribosyltransferase market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nicotinamide Phosphoribosyltransferase market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Nicotinamide Phosphoribosyltransferase Market Share Analysis
Nicotinamide Phosphoribosyltransferase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Nicotinamide Phosphoribosyltransferase business, the date to enter into the Nicotinamide Phosphoribosyltransferase market, Nicotinamide Phosphoribosyltransferase product introduction, recent developments, etc.

The major vendors covered:
Genentech, Inc.
Angelini Group
Calico LLC
FORMA Therapeutics, Inc.
OncoTartis, Inc.
Karyopharm Therapeutics, Inc.
Aurigene Discovery Technologies Limited
...


1 Study Coverage

  • 1.1 Nicotinamide Phosphoribosyltransferase Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Nicotinamide Phosphoribosyltransferase Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Type
    • 1.4.2 Hormone
    • 1.4.3 Lipids
    • 1.4.4 Small Molecule Compounds
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Application
    • 1.5.2 Parkinson's Disease
    • 1.5.3 Acute Lung Injury
    • 1.5.4 Breast Cancer
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Nicotinamide Phosphoribosyltransferase Market Size, Estimates and Forecasts
    • 2.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue 2015-2026
    • 2.1.2 Global Nicotinamide Phosphoribosyltransferase Sales 2015-2026
  • 2.2 Global Nicotinamide Phosphoribosyltransferase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Nicotinamide Phosphoribosyltransferase Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Nicotinamide Phosphoribosyltransferase Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Nicotinamide Phosphoribosyltransferase Competitor Landscape by Players

  • 3.1 Nicotinamide Phosphoribosyltransferase Sales by Manufacturers
    • 3.1.1 Nicotinamide Phosphoribosyltransferase Sales by Manufacturers (2015-2020)
    • 3.1.2 Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers
    • 3.2.1 Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers (2015-2020)
    • 3.2.2 Nicotinamide Phosphoribosyltransferase Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Nicotinamide Phosphoribosyltransferase Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Nicotinamide Phosphoribosyltransferase Revenue in 2019
    • 3.2.5 Global Nicotinamide Phosphoribosyltransferase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Nicotinamide Phosphoribosyltransferase Price by Manufacturers
  • 3.4 Nicotinamide Phosphoribosyltransferase Manufacturing Base Distribution, Product Types
    • 3.4.1 Nicotinamide Phosphoribosyltransferase Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Nicotinamide Phosphoribosyltransferase Product Type
    • 3.4.3 Date of International Manufacturers Enter into Nicotinamide Phosphoribosyltransferase Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Type (2015-2020)
    • 4.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2015-2020)
    • 4.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2015-2020)
    • 4.1.3 Nicotinamide Phosphoribosyltransferase Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Nicotinamide Phosphoribosyltransferase Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Type (2021-2026)
    • 4.2.3 Nicotinamide Phosphoribosyltransferase Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Nicotinamide Phosphoribosyltransferase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Application (2015-2020)
    • 5.1.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2015-2020)
    • 5.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2015-2020)
    • 5.1.3 Nicotinamide Phosphoribosyltransferase Price by Application (2015-2020)
  • 5.2 Nicotinamide Phosphoribosyltransferase Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Nicotinamide Phosphoribosyltransferase Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Nicotinamide Phosphoribosyltransferase by Country
    • 6.1.1 North America Nicotinamide Phosphoribosyltransferase Sales by Country
    • 6.1.2 North America Nicotinamide Phosphoribosyltransferase Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Type
  • 6.3 North America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Nicotinamide Phosphoribosyltransferase by Country
    • 7.1.1 Europe Nicotinamide Phosphoribosyltransferase Sales by Country
    • 7.1.2 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Type
  • 7.3 Europe Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Nicotinamide Phosphoribosyltransferase by Region
    • 8.1.1 Asia Pacific Nicotinamide Phosphoribosyltransferase Sales by Region
    • 8.1.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Type
  • 8.3 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Nicotinamide Phosphoribosyltransferase by Country
    • 9.1.1 Latin America Nicotinamide Phosphoribosyltransferase Sales by Country
    • 9.1.2 Latin America Nicotinamide Phosphoribosyltransferase Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Type
  • 9.3 Central & South America Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase by Country
    • 10.1.1 Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales by Country
    • 10.1.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Type
  • 10.3 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Genentech, Inc.
    • 11.1.1 Genentech, Inc. Corporation Information
    • 11.1.2 Genentech, Inc. Description and Business Overview
    • 11.1.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.1.5 Genentech, Inc. Related Developments
  • 11.2 Angelini Group
    • 11.2.1 Angelini Group Corporation Information
    • 11.2.2 Angelini Group Description and Business Overview
    • 11.2.3 Angelini Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Angelini Group Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.2.5 Angelini Group Related Developments
  • 11.3 Calico LLC
    • 11.3.1 Calico LLC Corporation Information
    • 11.3.2 Calico LLC Description and Business Overview
    • 11.3.3 Calico LLC Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Calico LLC Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.3.5 Calico LLC Related Developments
  • 11.4 FORMA Therapeutics, Inc.
    • 11.4.1 FORMA Therapeutics, Inc. Corporation Information
    • 11.4.2 FORMA Therapeutics, Inc. Description and Business Overview
    • 11.4.3 FORMA Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.4.5 FORMA Therapeutics, Inc. Related Developments
  • 11.5 OncoTartis, Inc.
    • 11.5.1 OncoTartis, Inc. Corporation Information
    • 11.5.2 OncoTartis, Inc. Description and Business Overview
    • 11.5.3 OncoTartis, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.5.5 OncoTartis, Inc. Related Developments
  • 11.6 Karyopharm Therapeutics, Inc.
    • 11.6.1 Karyopharm Therapeutics, Inc. Corporation Information
    • 11.6.2 Karyopharm Therapeutics, Inc. Description and Business Overview
    • 11.6.3 Karyopharm Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.6.5 Karyopharm Therapeutics, Inc. Related Developments
  • 11.7 Aurigene Discovery Technologies Limited
    • 11.7.1 Aurigene Discovery Technologies Limited Corporation Information
    • 11.7.2 Aurigene Discovery Technologies Limited Description and Business Overview
    • 11.7.3 Aurigene Discovery Technologies Limited Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.7.5 Aurigene Discovery Technologies Limited Related Developments
  • 11.1 Genentech, Inc.
    • 11.1.1 Genentech, Inc. Corporation Information
    • 11.1.2 Genentech, Inc. Description and Business Overview
    • 11.1.3 Genentech, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Products Offered
    • 11.1.5 Genentech, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Nicotinamide Phosphoribosyltransferase Market Estimates and Projections by Region
    • 12.1.1 Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Regions 2021-2026
  • 12.2 North America Nicotinamide Phosphoribosyltransferase Market Size Forecast (2021-2026)
    • 12.2.1 North America: Nicotinamide Phosphoribosyltransferase Sales Forecast (2021-2026)
    • 12.2.2 North America: Nicotinamide Phosphoribosyltransferase Revenue Forecast (2021-2026)
    • 12.2.3 North America: Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Nicotinamide Phosphoribosyltransferase Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Nicotinamide Phosphoribosyltransferase Sales Forecast (2021-2026)
    • 12.3.2 Europe: Nicotinamide Phosphoribosyltransferase Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Nicotinamide Phosphoribosyltransferase Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Nicotinamide Phosphoribosyltransferase Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Nicotinamide Phosphoribosyltransferase Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Nicotinamide Phosphoribosyltransferase Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Nicotinamide Phosphoribosyltransferase Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Nicotinamide Phosphoribosyltransferase Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Nicotinamide Phosphoribosyltransferase Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Nicotinamide Phosphoribosyltransferase Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Nicotinamide Phosphoribosyltransferase Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Nicotinamide Phosphoribosyltransferase Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Nicotinamide Phosphoribosyltransferase Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Nicotinamide Phosphoribosyltransferase Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Nicotinamide Phosphoribosyltransferase Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Summary:
    Get latest Market Research Reports on Nicotinamide Phosphoribosyltransferase. Industry analysis & Market Report on Nicotinamide Phosphoribosyltransferase is a syndicated market report, published as Global (United States, European Union and China) Nicotinamide Phosphoribosyltransferase Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Nicotinamide Phosphoribosyltransferase market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,014.70
    4,522.05
    6,029.40
    3,630.90
    5,446.35
    7,261.80
    595,491.00
    893,236.50
    1,190,982.00
    329,160.00
    493,740.00
    658,320.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report